This Sources Sought opportunity from Department Of Health And Human Services was posted on December 3, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Public Health Industrial Base Capabilities and Capacities: Anti-Microbials

Closed

75A50121CFederal

Submission Closed01/06/2025, 03:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325411

New

DIBBS

KETOROLAC TROMETHAMINEKetorolac Tromethamine Injection, USP 15 mg per mL in prefilled syringes, 24’s per unit, is being procured under contract SPE2DP-26-T-4143 for delivery to Fort Bragg, North Carolina, with a required delivery date of July 13, 2026, and a five-day delivery window. The item is identified by NSN 6505-01-666-2156 and NDC 76045-0107-10, manufactured by FRESENIUS KABI, LLC, and must comply with DLA’s Master List of Technical and Quality Requirements, including Packaging Requirement RP001 and Shelf-life requirement RS016, which mandates a non-extendable 24-month shelf life. All packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and units must be sealed in commercial containers that ensure protection from damage during transit. The product must be shipped by the fastest traceable means, excluding parcel post, and labeled according to current Hazard Communication Standards (29 C.F.R. 1910.1200), including OSHA-compliant Safety Data Sheets and labels, as mandated post-June 2015. The quantity is one unit of issue (PG), with zero variance permitted, and inspection and acceptance occur at the destination. Packaging and palletization must follow DLA specifications, and government identification must not appear on non-accepted supplies. The contract requires full compliance with all applicable DLA technical and quality requirements, which take precedence over ASTM D3951 or other general commercial standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

REHYDRATION SALTS FThe contract is for Rehydration Salts F, a regulated medical product under FDA oversight, requiring confirmation of compliance with marketing requirements including registration, labeling, and Good Manufacturing Practices, though a 510(k) may not be required. The item has a non-extendable 24-month shelf life and must be marked in accordance with the latest edition of Medical Marking Standard No. 1 and MIL-STD-129, with packaging conforming to MIL-STD-2073-1E and DLA packaging requirements. The product is identified by NSN 6505-01-731-1574 and supplier part number 61436, provided by DRIP DROP HYDRATION INC. A total of two cases are to be delivered FOB destination within five days of contract award, with no variance allowed in quantity. Delivery is to Fort Stewart, Georgia, and shipping must occur via the fastest traceable means, excluding parcel post. The required delivery date is July 16, 2026, and the solicitation closes on July 21, 2026. The contract uses the DoD unit of issue and includes specific markings, packaging codes, and government-only identifiers. The contracting officer must submit an EBS referral for FDA product confirmation, including manufacturer and bidder details.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ANALGESIC GEL, TOPICALThe contract specifies the procurement of an analgesic gel for topical use containing 5% menthol USP, supplied in 4 oz tubes with 144 tubes per case, classified as a flammable hazardous material requiring storage at 20–25°C (68–77°F) and protection from excessive heat or open flame. The item is identified by NSN 6505-01-658-7643 with a non-extendable shelf life of 24 months and must be packaged in commercial-grade containers that ensure protection from damage during transport, conforming to Medical Marking Standard No. 1 instead of MIL-STD-129. Shipment of the product must adhere to applicable hazard communication regulations, including the submission of Safety Data Sheets compliant with 29 C.F.R. 1910.1200 prior to award, and each shipment must include an accompanying SDS. Labels must meet OSHA’s revised Hazard Communication Standard aligned with the Globally Harmonized System, and supplier employees must be trained on these requirements. Packaging and transportation must comply with 49 CFR and ICAO regulations due to the flammable nature of the product, and all materials must be marked and documented in accordance with DLA’s hazardous material protocols, including electronic submission of SDS to DLA.MSDS@DLA.MIL. The contract is issued under solicitation SPE2DP-26-T-4115, requiring delivery within 20 days to Waterveciet, NY, and is managed by the Department of Defense’s Medical Supply Chain.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE AND MENTHOLBenzocaine and Menthol Lozenge, manufactured by RB Health US LLC and Reckitt Benckiser LLC, is a 15 mg benzocaine and 2.6 mg menthol oral pain reliever in honey lemon flavor, packaged in units of 16 lozenges, with a shelf life of 36 months that is non-extendable. The product must be stored at 20-25°C (68-77°F) and protected from humidity. All medical acquisitions require commercial packaging that ensures protection from damage or breakage, with each unit sealed in an appropriate container and shipped in exterior containers that guarantee safe, low-cost delivery to the destination. Material must be marked in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging must comply with DLA’s packaging requirements and palletization standards. The item is identified by NSN 6505017081449 and NDC 63824-0732-16, and is procured across five contract line items totaling 58 package units, each priced at $1.00 per unit, for total contract value of $58.00. Delivery is required within 20 days, FOB destination, with zero variance allowed in quantity, inspection and acceptance occurring at the delivery point. Shipments must be traceable, excluding parcel post, and sent to designated military logistics addresses at Fort Bragg, North Carolina, and Fort Stewart, Georgia. The solicitation, issued by the Department of Defense under contract SPE2DP-26-T-4113, has a response deadline of July 20, 2026, and requires compliance with all technical and quality requirements listed in the DLA Master List.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Manufacturing of Chlorine Test Strips (INSTA-TEST STRIPS Model 600S)

MEDICAL SUPPLY CHAIIN FSH

POSTED

1 day ago

DEADLINE

in 6 days

General Info

Agency

Department Of Health And Human ServicesView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

Washington, DC, 20515, USA

Set-Aside

NONE

Documents

(2)

HHS DPA T3 RFI_Antimicrobials - Clean copy 11-7-24 (002).docx

DOCX

HHS+DPA+T3+RFI_Antimicrobials+-+Updated+POC+1-22-25.docx

DOCX

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed

PostedDec 3

Sources Sought

Response DeadlineJan 6

Deadline has passed

Submission Closed

01/06/2025, 03:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services

Contacts1 person available

OfficeELLICOTT CITY, MD, 21042, USA

Organization / Agency

Department Of Health And Human Services

View Agency Profile

Office AddressELLICOTT CITY, MD, 21042, USA

Contacts

Chris Newell

contact@example.gov

Full Description

The HHS DPA Title III Program invite industry partners to submit to the USG information that will aid in improving the understanding of current domestic production capabilities and capacities of domestic PHIB that specifically support the production and supply of anti-microbials. The USG goal is to identify and improve on those gaps in the marketplace that can potentially be addressed using HHS delegated Title III authorities. Industry responses to the RFI are intended to assist the HHS DPA Title III Program with planning and market research. See the attached RFI and submit responses to Chris Newell at IBMSC-Submissions@hhs.gov. This RFI is extended. Please respond by January 6, 2025 at 10am ET.